FN2 Earnings Intelligence
Intuitive Surgical, Inc. ratios (quarterly)
Intuitive Surgical, Inc. (ISRG) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $2,573.8 | $3,403.1 | $2,806.6 | $2,006.5 | $2,760.4 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $2,253.4 | $2,440 | $2,505.1 | $2,770.8 | $2,892.3 | $2,902 | $3,213.3 |
| % Growth | - | - | - | - | - | 15.8% | - |
| Gross Profit | $1,457.7 | $1,617.9 | $1,662.4 | $1,830.5 | $1,960.4 | - | - |
| % Margin | 64.7% | 66.3% | 66.4% | 66.1% | 67.8% | - | - |
| EBITDA | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| Net Income | $698.4 | $658.4 | $704.4 | $821.5 | $818.1 | - | - |
| % Margin | 31.0% | 27.0% | 28.1% | 29.6% | 28.3% | - | - |
| Diluted EPS | $1.92 | $1.81 | $1.95 | $2.28 | $2.29 | $2.64 | $2.85 |
| % Growth | - | - | - | - | - | 35.3% | - |
| Operating Cash Flow | $581.6 | - | - | $911.9 | - | - | - |
| CapEx | $116.6 | - | - | $103.3 | - | - | - |
| Free Cash Flow | $465 | - | - | $808.6 | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $2,253.4 | $2,440 | $2,505.1 | $2,770.8 | $2,892.3 | $2,902 | $3,213.3 |
| Gross Profit | $1,457.7 | $1,617.9 | $1,662.4 | $1,830.5 | $1,960.4 | - | - |
| EBITDA | - | - | - | - | - | - | - |
| Net Income | $698.4 | $658.4 | $704.4 | $821.5 | $818.1 | - | - |
| Diluted EPS | $1.92 | $1.81 | $1.95 | $2.28 | $2.29 | $2.64 | $2.85 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $2,573.8 | $3,403.1 | $2,806.6 | $2,006.5 | $2,760.4 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $581.6 | - | - | $911.9 | - |
| Capital Expenditure | $116.6 | - | - | $103.3 | - |
| Free Cash Flow | $465 | - | - | $808.6 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 64.7% | 66.3% | 66.4% | 66.1% | 67.8% |
| EBITDA Margin | - | - | - | - | - |
| Net Margin | 31.0% | 27.0% | 28.1% | 29.6% | 28.3% |
| FCF Margin | 20.6% | - | - | 29.2% | - |
| Diluted EPS Growth | - | - | - | - | - |